Cycloset Explored as Add-on Therapy for Type 2 Diabetes on GLP-1s
Effect of Cycloset on Glycemic Control When Added to Glucagon-like Peptide 1 (GLP-1) Analogue Therapy
Abstract
Effect of Cycloset on Glycemic Control in Type 2 Diabetic Patients Inadequately Controlled on GLP-1 Analogue Therapy
NCT ID: NCT02299050
Status: COMPLETED
Sponsor: The University of Texas Health Science Center at San Antonio
Phase: PHASE4…